GRANDI, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 9.919
AS - Asia 5.338
EU - Europa 4.136
SA - Sud America 919
AF - Africa 126
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 1
Totale 20.477
Nazione #
US - Stati Uniti d'America 9.791
SG - Singapore 1.668
CN - Cina 1.656
GB - Regno Unito 1.018
IT - Italia 921
HK - Hong Kong 908
BR - Brasile 734
SE - Svezia 525
DE - Germania 428
VN - Vietnam 377
RU - Federazione Russa 310
FI - Finlandia 186
UA - Ucraina 142
KR - Corea 122
ID - Indonesia 101
BG - Bulgaria 98
FR - Francia 97
NL - Olanda 95
TR - Turchia 95
IN - India 89
AR - Argentina 83
CA - Canada 57
PL - Polonia 52
JP - Giappone 51
ES - Italia 41
BD - Bangladesh 40
MX - Messico 40
IQ - Iraq 39
AU - Australia 37
LT - Lituania 35
IE - Irlanda 34
ZA - Sudafrica 34
MY - Malesia 26
EC - Ecuador 25
ET - Etiopia 22
AT - Austria 21
CO - Colombia 18
PK - Pakistan 17
IL - Israele 16
IR - Iran 16
MA - Marocco 16
CL - Cile 15
SI - Slovenia 15
SA - Arabia Saudita 14
PH - Filippine 13
IS - Islanda 12
KZ - Kazakistan 12
VE - Venezuela 11
BE - Belgio 10
JO - Giordania 10
PT - Portogallo 10
PY - Paraguay 10
TN - Tunisia 10
UZ - Uzbekistan 10
AE - Emirati Arabi Uniti 9
BO - Bolivia 9
CZ - Repubblica Ceca 9
HR - Croazia 9
KE - Kenya 9
RO - Romania 8
CH - Svizzera 7
LV - Lettonia 7
PE - Perù 7
RS - Serbia 7
DO - Repubblica Dominicana 6
EG - Egitto 6
GR - Grecia 6
HU - Ungheria 6
MD - Moldavia 6
AL - Albania 5
AZ - Azerbaigian 5
DK - Danimarca 5
GE - Georgia 5
HN - Honduras 5
NP - Nepal 5
PA - Panama 5
SN - Senegal 5
UY - Uruguay 5
AM - Armenia 4
JM - Giamaica 4
QA - Qatar 4
TW - Taiwan 4
BH - Bahrain 3
BY - Bielorussia 3
CM - Camerun 3
CR - Costa Rica 3
NG - Nigeria 3
OM - Oman 3
TH - Thailandia 3
BB - Barbados 2
CG - Congo 2
CI - Costa d'Avorio 2
DZ - Algeria 2
GT - Guatemala 2
GY - Guiana 2
KG - Kirghizistan 2
LB - Libano 2
LU - Lussemburgo 2
NO - Norvegia 2
SC - Seychelles 2
Totale 20.448
Città #
Santa Clara 1.465
Ashburn 990
Singapore 968
Fairfield 927
Hong Kong 901
Chandler 646
Hefei 515
Southend 495
Woodbridge 466
Seattle 358
Nyköping 346
Houston 337
Cambridge 331
London 314
Dallas 293
Beijing 292
Wilmington 284
Jacksonville 220
Dearborn 207
Los Angeles 205
Ann Arbor 193
Chicago 162
Ho Chi Minh City 154
Modena 148
New York 132
Princeton 120
Seoul 116
Helsinki 111
The Dalles 98
San Diego 97
Sofia 97
Moscow 84
Milan 79
Munich 76
Shanghai 73
Jakarta 72
Bremen 71
Hanoi 70
São Paulo 67
Salt Lake City 66
Rome 65
Bologna 60
Buffalo 58
Eugene 55
Belo Horizonte 41
Izmir 39
Tokyo 36
Warsaw 36
Columbus 34
Dublin 34
Redondo Beach 31
Stockholm 30
Elk Grove Village 27
Amsterdam 26
Kent 26
Redwood City 26
Turku 25
Guangzhou 24
Baghdad 23
Brooklyn 23
Denver 23
Council Bluffs 22
Atlanta 21
Nuremberg 21
Orem 21
Düsseldorf 20
Lauterbourg 20
Montreal 20
Tampa 20
Cardiff 19
Rio de Janeiro 19
Dronten 18
Frankfurt am Main 18
Norwalk 18
Phoenix 18
San Jose 18
San Francisco 17
Haiphong 16
Portsmouth 16
San Mateo 16
Johannesburg 15
Lappeenranta 15
Orsogna 15
Falls Church 14
Lille 14
Poplar 14
Boardman 13
Chennai 13
Jinan 13
Mexico City 13
Miami 13
Naples 13
San Giuliano Milanese 13
Boston 12
Da Nang 12
Grafing 12
Kraków 12
Verona 12
Wuhan 12
Brasília 11
Totale 14.007
Nome #
Intensity of menstrual pain and estimated angle of uterine flexion 385
Estradiol in hormonal contraception: real evolution or just same old wine in a new bottle? 375
A comprehensive review of hormonal and biological therapies for endometriosis: latest developments 322
Association between urinary incontinence and climacteric symptoms in postmenopausal women 294
Impact of laparoscopic cystectomy of endometriotic and non-endometriotic cysts on ovarian volume, antral follicle count (AFC) and ovarian doppler velocimetry 288
A regional audit system for stillbirth: A way to better understand the phenomenon 285
Adenomyosis of the Extrapelvic Portion of the Round Ligament 283
Intermenstrual pelvic pain, quality of life and mood 276
Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes 263
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History 262
Metabolic impact of combined hormonal contraceptives containing estradiol 257
Brca detection rate in an italian cohort of luminal early-onset and triple-negative breast cancer patients without family history: When biology overcomes genealogy 256
Body composition and resting metabolic rate of perimenopausal women using continuous progestogen contraception 255
The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life 250
Reproductive risk factors in women with family history of breast cancer attending an Italian Family Cancer Clinic 249
Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea 248
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study 246
Levonorgestrel-releasing intra-uterine systems as female contraceptives 246
Pelvic Pain and Quality of Life of Women With Endometriosis During Quadriphasic Estradiol Valerate/Dienogest Oral Contraceptive. A Patient-Preference Prospective 24-Week Pilot Study 244
Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol 237
Pharmacokinetic evaluation of desogestrel as a female contraceptive 234
Induction of Labor According to Medical Indications: A Critical Evaluation through a Prospective Study 232
Dienogest-based hormonal contraception induced changes in the ultrasound presentation of the uterus and menstrual pain 229
Combined hormonal contraceptives in BRCA gene mutation carriers: why not? 228
Vaginal alpha-lipoic acid shows an anti-inflammatory effect on the cervix, preventing its shortening after primary tocolysis. A pilot, randomized, placebo-controlled study 218
The association between progestins, nuclear receptors expression and inflammation in endometrial stromal cells from women with endometriosis 216
The Jellyfish Sign: A New Sonographic Cervical Marker to Predict Maternal Morbidity in Abnormally Invasive Placenta Previa 216
Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers 215
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation 211
Increasing BMI is associated with both endometrioid and serous histotypes among endometrial rather than ovarian cancers: a case-to-case study 211
Prevalence of menstrual pain in young women: What is dysmenorrhea? 208
Does dienogest influence the inflammatory response of endometriotic cells? A systematic review 205
The Association of Four Natural Molecules-EGCG, Folic Acid, Vitamin B12, and HA-To Counteract HPV Cervical Lesions: A Case Report 199
Hereditary ovarian cancers: State of the art 197
Postmenopausal hormone therapy in BRCA gene mutation carriers: to whom and which? 194
Easy tools to screen Italian women suffering from migraine with and without aura in early reproductive age 193
Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol 190
Inflammation influences steroid hormone receptors targeted by progestins in endometrial stromal cells from women with endometriosis 186
Combined oral contraceptive with estetrol plus drospirenone: from pharmacokinetics to clinical applications 185
Hormonal contraception in women with endometriosis: a systematic review 184
BRCA mutation carriers' perceptions on postmenopausal hormone therapy: An Italian study 184
Dienogest mediates midkine suppression in endometriosis 183
Progestin suppressed inflammation and cell viability of tumor necrosis factor-α-stimulated endometriotic stromal cells 180
The generally low sensitivity of CA125 for FIGO stage I ovarian cancer diagnosis increases for endometrioid histotype 180
Can immunohistochemistry improve the pathological diagnosis of placenta accreta spectrum (PAS) disorders? 176
Carboplatin-paclitaxel in triple-negative metastatic breast cancer during pregnancy with neoplastic thrombosis 176
BRCA mutation carriers’ perception about benefits and risks associated with combined hormonal contraceptives use 171
Attitudes of women towards products containing hormones (hormonal contraceptives or hormone therapy): what changes from pre to postmenopause? 169
A first trimester prediction model for large for gestational age infants: a preliminary study 168
Satisfaction with prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers is very high and little dependent on the participants' characteristics at surgery: a prospective study 165
Current and future hormonal contraception in Italy: results from an Italian consensus expert meeting 163
Vitamin D and green tea extracts for the treatment of uterine fibroids in late reproductive life: a pilot, prospective, daily-diary based study 160
Drospirenone 4 mg-only pill (DOP) in 24+4 regimen: a new option for oral contraception 159
Attitudes towards menstruation: what women want? An Italian National Survey 157
Surface roughness of different contraceptive vaginal rings: evaluation by scanning electron microscope (SEM) 156
The reduction of CA 125 serum levels in BRCA 1/2 mutation carriers after risk-reducing salpingo-oophorectomy is only partially associated with surgery: A prospective cohort, other biomarker controlled, study 154
A 10-year report from a multicentre randomised controlled trial: Immediate non-occlusal versus early loading of dental implants in partially edentulous patients 150
Drospirenone 4 mg in a 24 + 4 regimen in women with contraindications to oestrogen use for contraception: bleeding patterns according to previous menstrual characteristics 145
Primary fallopian tube carcinoma (PFTC) in a BRIP-1 mutation carrier: the first case report 143
The impact of COVID-19 lockdown on admission to gynecological emergency departments: Results from a multicenter Italian study 141
The use of different doses levonorgestrel-releasing intrauterine system (LNG-IUS): real-world data from a multicenter Italian study 140
Use of hormonal contraception in italian university students 138
The paradigm of norgestimate: a third-generation testosterone-derivative progestin with a peripheral anti-androgenic activity and the lowest risk of venous thromboembolism 138
Soluzioni di design per viti di connessione implantare: studio agli elementi finiti. 137
A new progestin-only pill (POP): the impact of drospirenone-only pill 4 mg 24 + 4 on coagulation markers and bleeding patterns 135
Estetrol (E4): the new estrogenic component of combined oral contraceptives 135
Contemporary prescriptions pattern of different dose levonorgestrel-releasing intrauterine systems in an Italian service for family planning 135
Eziologia del dolore pelvico cronico e qualità di vita. 133
A comparison of two implants with conical vs internal hex connections: 1-year post-loading results from a multicentre, randomised controlled trial 133
Breast cancer screening of mutation carriers in the era of COVID-19 pandemic 131
Estradiol in non-oral hormonal contraception: a “long and winding road” 130
Contraception during Coronavirus-Covid 19 pandemia. Recommendations of the Board of the Italian Society of Contraception 129
Chemoprevention strategies in hereditary breast and ovarian cancer syndromes 126
The challenging screen detection of ovarian cancer in BRCA mutation carriers adhering to a 6-month follow-up program: results from a 6-years surveillance 125
Laparoscopic management of ectopic pregnancies: a comparison between interstitial and “more distal” tubal pregnancies 125
The gendered impact of coronavirus disease (COVID-19): do estrogens play a role? 124
Prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers: what is going on in a region of northern Italy? 123
Hormonal Contraception in perimenopausal women 122
The drospirenone (DRSP)-only pill: clinical implications in the daily use 120
Contraception and Cardiovascular Diseases 119
Prevalenza e caratteristiche del dolore mestruale in giovani donne 116
Trattamento medico dell'endometriosi: progestinici e formulazioni estro-progestiniche 115
Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations 114
The impact of epidural analgesia on delivery mode in Robson class 1 women: a retrospective cohort study 111
A 3-year report from a multicentre randomised controlled trial: Immediately versus early loaded implants in partially edentulous patients 109
The role of combined oral contraceptives containing norgestimate for acne vulgaris treatment: a review 108
Fattori di rischio cardiovascolare, dolore mestruale e qualità di vita con contraccettivi orali contenenti estradiolo valerato/dienogest vs etinilestradiolo/clormadinone acetato: trial prospettico, randomizzato. 107
Future directions in endometriosis treatment: discovery and development of novel inhibitors of estrogen biosynthesis 106
Molecole di adesione tissutale ed endometriosi 105
Contraception During Perimenopause: Practical Guidance 104
Wide diameter immediate post-extractive implants vs delayed placement of normal-diameter implants in preserved sockets in the molar region: 1-year post-loading outcome of a randomised controlled trial 103
Immediate loading of two unsplinted implants retaining the existing complete mandibular denture in elderly edentulous patients: 1-year results from a multicentre prospective cohort study 103
Lipid metabolism, insulin resistance, blood pressure and body composition with oral contraceptives containing astradiol valerato/dienogest vs ethinylestradiol/chlormadinone: a prospective, randomized trial. 101
Implant site preparation using a single bur versus multiple drilling steps: 4-month post-loading results of a multicenter randomised controlled trial 101
Prevalenza e fattori di rischio di dismenorrea in studentesse universitarie italiane 100
Short-term effects of metformin and myo-inositol in women with polycystic ovarian syndrome (PCOS): a meta-analysis of randomized clinical trials 100
It is time to talk about replacement of subdermal implants from the same cut, is it always feasible? The slow process of the "armpit approach" 100
Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other Than BRCA 96
Miglioramento della qualità di vita con contraccettivo orale in donne affette da dismenorrea primaria 95
Immediate, early (3 weeks) and conventional loading (4 months) of single implants: Preliminary data at 1 year after loading from a pragmatic multicenter randomised controlled trial 95
Totale 17.639
Categoria #
all - tutte 99.857
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.857


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.032 0 0 0 0 0 0 128 203 129 213 134 225
2021/20221.592 187 97 77 37 46 138 34 76 260 166 238 236
2022/20231.985 280 265 137 144 223 270 42 153 235 38 99 99
2023/20241.623 68 86 62 162 270 133 159 216 99 82 106 180
2024/20255.513 138 81 82 386 1.070 795 329 290 716 425 535 666
2025/20265.458 721 420 1.105 1.105 1.404 699 4 0 0 0 0 0
Totale 20.704